Exelixis
EXEL
#1299
Rank
NZ$31.05 B
Marketcap
NZ$127.27
Share price
3.12%
Change (1 day)
72.95%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company